Active Surveillance for Bethesda IV Thyroid Nodules

The traditional surgical approach for Bethesda IV thyroid nodules burdens healthcare systems and patients with costs, perioperative morbidity, and potential long-term consequences of hemithyroidectomy, including hypothyroidism (requiring lifelong thyroid hormone replacement), nerve damage, infection, voice discomfort and postoperative bleeding. Moreover, patient-reported anxiety and reduced quality of life often follow surgery, regardless of benign final pathology. Conversely, surveillance strategies that include periodic ultrasound assessment, clinical examination, and patient education may r

Trial Details

NCT ID
NCT07370675
Phase
NA
Sponsor
Christian Grønhøj Larsen
Status
RECRUITING
Cancer Type
Thyroid Cancer
Interventions
  • Active surveillance (6, 12, 18, 24, 36, 48, 60 months)
Locations (sample)
  • Copenhagen, Denmark|55.67594,12.56553

Key Eligibility Criteria

  • age of 30 years or older AND
  • a single nodule with a Follicular neoplasm or suspicious for a follicular neoplasm (category IV in the Bethesda system) AND
  • tumor size of less than 2 cm in all dimensions AND
  • EU-TIRADS 3 or 4 in Ultrasound imaging examination.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Thyroid Cancer Trials on Trialify →